MarketScreener Editorial Features Cytokinetics, Incorporated Deutsche Boerse AG
Equities
KK3A
US23282W6057
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.8 EUR | -0.40% | +2.89% | -32.70% |
01:30pm | Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants | CI |
06-11 | Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing | MT |
MarketScreener Editorial Features
Stocks in motion: e.l.f Beauty soars along with Nvidia | May 23, 2024 at 11:36 am | |
Today on Wall Street: Breaking record after record | August 13, 2021 at 09:05 am |
- Stock Market
- Equities
- CYTK Stock
- KK3A Stock
- News Cytokinetics, Incorporated
- MarketScreener Editorial Features